Literature DB >> 22778370

Spontaneous regression of focal nodular hyperplasia: a pathological report.

H Laumonier1, F Leblanc, C Balabaud, P Bioulac-Sage.   

Abstract

Focal nodular hyperplasia (FNH) is a benign tumour of the liver, occurring in 0.6-3% of the general population. Most lesions are diagnosed incidentally. With the increasing use and improvement of diagnostic imaging, FNH is being observed more often. It has been shown, using radiological approaches, that most FNH remain stable, or even regress, over a long follow-up period. In addition, it is extremely rare that FNH were discovered in elderly. However, to our knowledge, there is no pathological report illustrating the regression of FNH. We report here a case showing the pathological changes occurring during the regression phase of FNH, with dense fibrous tissue mixed with arteries replacing hepatocytes nodules.

Entities:  

Mesh:

Year:  2010        PMID: 22778370      PMCID: PMC3027794          DOI: 10.1136/bcr.02.2010.2704

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Oral contraceptive use and focal nodular hyperplasia of the liver.

Authors:  D Mathieu; H Kobeiter; P Maison; A Rahmouni; D Cherqui; E S Zafrani; D Dhumeaux
Journal:  Gastroenterology       Date:  2000-03       Impact factor: 22.682

Review 2.  Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update.

Authors:  P Bioulac-Sage; C Balabaud; P Bedossa; J Y Scoazec; L Chiche; A P Dhillon; L Ferrell; V Paradis; T Roskams; V Vilgrain; I R Wanless; J Zucman-Rossi
Journal:  J Hepatol       Date:  2007-01-02       Impact factor: 25.083

3.  Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Anne Rullier; Gaelle Cubel; Christophe Laurent; Jessica Zucman-Rossi; Charles Balabaud
Journal:  Liver Int       Date:  2008-09-18       Impact factor: 5.828

4.  Letter: Regression of focal nodular hyperplasia after discontinuation of oral contraceptives.

Authors:  D Ross; J Pina; M Mirza; A Galvan; L Ponce
Journal:  Ann Intern Med       Date:  1976-08       Impact factor: 25.391

5.  Regression of focal nodular hyperplasia of the liver after oral contraceptive discontinuation.

Authors:  C Côté
Journal:  Clin Nucl Med       Date:  1997-09       Impact factor: 7.794

6.  Spontaneous regression of focal nodular hyperplasia of the liver.

Authors:  Kenji Ohmoto; Toshihiro Honda; Mitsuyoshi Hirokawa; Yasuhiro Mitsui; Yasutaka Iguchi; Makoto Kuboki; Shinichiro Yamamoto
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

7.  Indication for treatment and long-term outcome of focal nodular hyperplasia.

Authors:  Glenn K Bonney; Dhanwant Gomez; Ahmed Al-Mukhtar; Giles J Toogood; J Peter A Lodge; Raj Prasad
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

8.  Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.

Authors:  Christoph J Zech; Luigi Grazioli; Josy Breuer; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Invest Radiol       Date:  2008-07       Impact factor: 6.016

9.  Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MR imaging analysis.

Authors:  Valérie Vilgrain; Florence Uzan; Giuseppe Brancatelli; Michael P Federle; Magali Zappa; Yves Menu
Journal:  Radiology       Date:  2003-08-27       Impact factor: 11.105

10.  [Regression of a focal nodular hyperplasia after stopping oral contraceptives].

Authors:  F Meunier; L Boyer; A Abergel; N Perez; A Ravel; F Lhopital; J F Viallet
Journal:  J Radiol       Date:  1998-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.